Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea

OBJECTIVE: Two phase I studies of darinaparsin including Japanese and Korean patients with relapsed/refractory peripheral T-cell lymphoma were performed to evaluate its safety (primary purpose), efficacy and pharmacokinetic profile (ClinicalTrials.gov: NCT01435863 and NCT01689220). METHODS: Patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Jpn J Clin Oncol
Päätekijät: Ogura, Michinori, Kim, Won-Seog, Uchida, Toshiki, Uike, Naokuni, Suehiro, Youko, Ishizawa, Kenichi, Nagai, Hirokazu, Nagahama, Fumiko, Sonehara, Yusuke, Tobinai, Kensei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869082/
https://ncbi.nlm.nih.gov/pubmed/33051668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa177
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia